ENXTBR:ARGX
ENXTBR:ARGXBiotechs

New VYVGART Data Might Change The Case For Investing In argenx (ENXTBR:ARGX)

argenx SE recently presented new data for VYVGART® and its efgartigimod pipeline at the 2025 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and the Myasthenia Gravis Foundation of America (MGFA) Scientific Session in San Francisco. These clinical updates, which include pivotal trial and real-world data across multiple patient subgroups, highlight advances in treating generalized myasthenia gravis and support ongoing innovation in rare neuromuscular...
ENXTBR:UMI
ENXTBR:UMIChemicals

Umicore (ENXTBR:UMI) Is Up 10.3% After Unlocking €410 Million by Selling Gold Inventories—What's Changed

In October 2025, Umicore announced it had sold its permanently tied up gold inventories from its Jewelry & Industrial Metals and Precious Metals Refining business units, generating €410 million in net proceeds and a significant after-tax capital gain of €370 million. This move enables Umicore to strengthen its balance sheet and optimize financing costs by shifting to revolving metal leases, increasing financial flexibility while maintaining operational effectiveness. Let's explore how...
ENXTBR:COLR
ENXTBR:COLRConsumer Retailing

Is Colruyt a Bargain After Shares Drop 16% Despite Solid Cash Flow Outlook?

If you own Colruyt Group stock, or are watching from the sidelines for the right entry point, you are not alone. The company’s recent performance has definitely raised a few eyebrows and stirred up some debate. Over the past year, Colruyt shares have shed 22.5%, continuing a downward trend that deepened with a 16.2% drop over the last 30 days alone. Year to date, the stock is off by 12.8%. That sounds rough, but if you zoom out a bit, you’ll see a three-year return of 53.6%, demonstrating...
ENXTBR:PROX
ENXTBR:PROXTelecom

What Does Proximus’s 43% 2025 Rally Mean for Investors After Market Optimism?

If you are watching Proximus and wondering what to do next, you are not alone. With a share price that just closed at 7.3, investors have every reason to re-examine the stock’s direction. Over the last week, Proximus slipped by 0.9%, but that comes after a solid 1.0% climb in the last month and an impressive year-to-date surge of 43.3%. Looking back over the past year, the stock is up 17.0%, a stark contrast to where things stood five years ago with a drop of 37.4% over that period. What is...
ENXTBR:DECB
ENXTBR:DECBBuilding

Exploring Three Undiscovered Gems In The European Market

As the European markets navigate a complex landscape of interest rate policies and trade tensions, the pan-European STOXX Europe 600 Index has remained relatively stable, while major stock indexes in Italy, Germany, France, and the UK have shown modest gains. In this environment of cautious optimism and selective growth across sectors, identifying promising stocks involves looking at companies with strong fundamentals that can thrive amid fluctuating economic indicators.
ENXTBR:SPA
ENXTBR:SPABeverage

Exploring October 2025's Undiscovered Gems in Europe

As the pan-European STOXX Europe 600 Index remains relatively stable amidst ongoing assessments of interest rate policies and trade tensions, major indices like Italy's FTSE MIB and Germany's DAX have shown modest gains, reflecting a cautiously optimistic market sentiment. In this environment, identifying potential growth opportunities requires a keen eye for stocks that not only demonstrate resilience but also possess the ability to capitalize on emerging economic trends.